PT Jayamas Medica Industri Tbk (ISX:OMED) ROCE % : 14.02% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is PT Jayamas Medica Industri Tbk ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Jayamas Medica Industri Tbk's annualized ROCE % for the quarter that ended in Mar. 2024 was 14.02%.

PT Jayamas Medica Industri Tbk ROCE % Historical Data

The historical data trend for PT Jayamas Medica Industri Tbk's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Jayamas Medica Industri Tbk ROCE % Chart

PT Jayamas Medica Industri Tbk Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

50.39

99.15

57.63

21.06

14.64

PT Jayamas Medica Industri Tbk Quarterly Data
	Dec19	Dec20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial								12.63	12.91	15.64	17.93	14.02

PT Jayamas Medica Industri Tbk ROCE % Calculation

PT Jayamas Medica Industri Tbk's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	345574.944	/	( ( (2507318.881 - 230946.309)	+	(2581482.597 - 136134.311) )	/ 2 )
	=	345574.944	/	( (2276372.572	+	2445348.286)	/ 2 )
	=	345574.944	/	2360860.429
	=	14.64 %

PT Jayamas Medica Industri Tbk's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	347410.2	/	( ( (2581482.597 - 136134.311)	+	(2646510.813 - 134463.795) )	/ 2 )
	=	347410.2	/	( ( 2445348.286	+	2512047.018 )	/ 2 )
	=	347410.2	/	2478697.652
	=	14.02 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

PT Jayamas Medica Industri Tbk (ISX:OMED) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PT Jayamas Medica Industri Tbk ROCE % Related Terms

Thank you for viewing the detailed overview of PT Jayamas Medica Industri Tbk's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Jayamas Medica Industri Tbk (ISX:OMED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT Jayamas Medica Industri Tbk (ISX:OMED) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sebelah Selatan Jalan By Pass RT 05 / RW 01, Kelurahan Sidomojo, Kecamatan Krian, Sidoarjo, Jawa Timur, East Java, IDN, 61262

Website

https://www.onemed.co.id

PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing medical devices and other household health supplies. It initially began with the manufacture of urine bags, OneMed later expanded in the manufacturing business of medical equipment and supplies in Indonesia with a range of variants of products manufactured locally. The Company and its Subsidiaries has three main divisions: Manufacturing; Distribution and Retail.